EHRA 2023: Late-Breaking Science Video Collection

Published: 18 April 2023

  • Views:

    Views Icon 2193
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating


For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice. 

About the episode

EHRA 23 - In this short interview, Prof Roland Tilz (University Heart Centre Lübeck, DE) outlines the findings from the POTTER registry. 

The POTTER Registry (NCT05273645) gathered data on patients undergoing pulmonary vein isolation (PVI) with a rare complication, atrio-oesophageal fistula (AOF). The registry focuses on the incidence, diagnosis and management of this complication, which affects around 0.016-0.07% of PVI patients. Prof Tilz outlines the patient population, key findings and future prospects of this worldwide, multicenter, retrospective registry. 

1. What was the rationale behind the creation of this registry?
2. What was the patient population and registry design?
3. What were the key findings?
4. How should these findings inform and shape practice?

A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study

Recorded on-site at EHRA 2023, Barcelona.

Editor: Jordan Rance

Faculty Biographies

Roland R Tilz

Roland R Tilz

Prof Roland Tilz is the deputy director of the Medical Center II of the University Hospital in Lübeck and professor of the invasive electrophysiology at the University Lübeck. He is committed to training in the field of “Invasive electrophysiology and cardiac rhythm implants”. Prof Roland Tilz trained at the Addenbrooks Hospital in Cambridge (UK), Bedford Hospital (UK), Klinikum Bayreuth and at the Asklepios Klinik St. Georg in Hamburg. 


View full profile


You must be to comment. If you are not registered, you can register here.